Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Immune System No Longer Autonomous?

Gretchen Henkel  |  Issue: May 2010  |  May 1, 2010

How do we take this knowledge forward to make a difference for patients with RA, nearly half of whom, asked Dr. Tak, are currently suffering from active disease? The bottom line, according to all three researchers, is to acknowledge this new view of the immune system. “Before, we tended to think about immunity as a distributed, non-innervated network that functions autonomously,” said Dr. Tracey. The immune system must now be regarded as an “innervated organ,” in his words, and that innervation occurs through a hard-wired network. The bonus reaped from in vivo studies is that we now better understand how the nervous system is sensing and responding to inflammatory mediators. This knowledge can lead to development of logical therapeutic targets to down-regulate the inflammatory process. Dr. Tracey and his colleagues are investigating the utility of vagal nerve stimulation. Some alpha 7 agonists could perhaps selectively deliver the right message to down-regulate the proinflammatory process and ongoing investigations are also showing some promise for the use of such mind–body techniques as paced breathing for the same purpose.8

Whatever the method, targeted therapeutics will be the wave of the future, helped by the kind of “cross-talk” and cross-fertilization demonstrated by these three investigators.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Gretchen Henkel is a medical journalist based in California.

References

  1. Borovikova LF, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462.
  2. Bernik TR, Friedman SG, Ochani M, et al. Cholinergic anti-inflammatory pathway inhibition of TNF during ischemia reperfusion. J Vasc Surg. 2002;36: 1231-1236.
  3. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-388.
  4. Sorkin LS, Moore J, Boyle DL, et al. Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol. 2003;184:162-168.
  5. Boyle DL, Moore J, et al. Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis. Arthritis Rheum. 2002;46:3076-3082.
  6. van Maanen MA, Stoof SP, et al. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 2009;60:1272-1281.
  7. van Maanen MA, Lebre MC, van der Poll T, et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 2009;60:114-122.
  8. Marsland AL, Gianaros PJ, Prather AA, et al. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosomatic Med. 2007; 69:709-716.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:ImmunityinflammationInterleukintumor necrosis factor

Related Articles

    Research Update: Using Vagus Nerve Stimulation for Rheumatic Disease

    April 8, 2023

    Over the past decade, a number of pilot studies have provided proof of concept for the use of vagus nerve stimulation (VNS) to treat rheumatic conditions. The studies represent an expansion of this treatment approach into rheumatology, building on years of scientific inquiry into the mechanisms of VNS on disease states that led to preclinical…

    Studies Probe Treating Rheumatoid Arthritis with Vagus Nerve Stimulation

    June 14, 2021

    When rheumatologists think about rheumatoid arthritis (RA), they are apt to picture the synovium, contemplate such antibodies as rheumatoid factor and those to citrullinated proteins, and consider how this interplay of factors manifests in disease. What is not as commonly discussed is the role the autonomic nervous system plays in the pathogenesis and symptomatology of…

    Meet the Lumbar Spinal Stenosis Challenge

    August 1, 2007

    Limited evidence and diagnostic options make this increasing condition difficult to treat

    Heart Rate Variability to Predict Treatment Response in Patients with RA

    August 17, 2015

    A growing understanding of the immuno­modulatory effect of the autonomic nervous system (ANS) is edging closer to having clinical applications that could one day benefit patients with rheumatoid arthritis (RA). Researchers pursuing this as an alternative path to biomarkers are investigating whether autonomic status can be used to predict response to therapy. Seattle-area rheumatologist and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences